In about 5% of AML cases, a chromosomal translocation fuses NSD1 to NUP98 to generate a NUP98–NSD1 chimera, which is sufficient to induce AML in vivo [147,148]. The gene discussed is NSD1; the disease is acute myeloid leukemia.